CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company focused primarily on products for the treatment of acute and chronic pain and other pain-related conditions, today announced the appointment of Jacques F. Rejeange to its Board of Directors effective immediately.
